← back to search

Xuewen Tan

Ministry of Education of the People's Republic of China · CN
Area of research
Rheumatology · Cancer Research
Research interest
Research topics from publications: CAR-macrophage: A new immunotherapy candidate against solid tumors; Growth arrest‐specific transcript 5 represses endometrial cancer development by promoting antitumor function of tumor‐associated macrophages; The essential role of long non-coding RNA GAS5 in glioma: interaction with microRNAs, chemosensitivity and potential as a biomarker; MicroRNA-10b promotes arthritis development by disrupting CD4+ T cell subtypes; MicroRNA-22 represses glioma development via activation of macrophage-mediated innate and adaptive immune responses. Representative work: Chimeric antigen receptor (CAR)-T cell therapy has been shown to be an effective treatment for hematological tumors, but the treatment of solid tumors still lacks effectiveness. In the tumor microenvironment, macrophages are the innate immune cells with the highest infiltration rate. Tumor-associated macrophages (TAMs) stimulate angiogenesis, increase tumor invasion, and mediate immunosuppression. Because macrophages can infiltrate solid tumor tissue and interact with almost all cellular components in the tumor microenvironment (including tumor cells, immune cells such as T-cells, NK cells, DCs, and other resident non-immune cells), researchers are trying to use macrophages modified with CAR The tumor-suppressor role of long noncoding RNA (lncRNA) growth arrest-specific transcript 5 (GAS5) has been proven in various types of cancer. However, the specific function of GAS5 in tumor-associated macrophages (TAMs) of endometrial cancer (EC) is elusive. Quantitative PCR results showed that GAS5 expression decreased in EC tissues and primary TAMs from EC tumors. Tumor-associated macrophage infiltration was significantly positively associated with the developmental stage of EC. Direct coculture of GAS5-overexpressing TAMs and EC cells showed that GAS5 enhanced phagocytosis, antigen presentation, and activation of cytotoxic T cells, and repressed "Don't eat me" signals between TAMs and E
h-index
citations
0
works
0
NIH funding
primary concept
email

Recent publications

Growth arrest‐specific transcript 5 represses endometrial cancer development by promoting antitumor function of tumor‐associated macrophages
Cancer Science 2022cited by 24position: middledoi
MicroRNA-22 represses glioma development via activation of macrophage-mediated innate and adaptive immune responses
Oncogene 2022cited by 10position: middledoi
CAR-macrophage: A new immunotherapy candidate against solid tumors
Biomedicine & Pharmacotherapy 2021cited by 230position: middledoi
MicroRNA-10b promotes arthritis development by disrupting CD4+ T cell subtypes
Molecular Therapy — Nucleic Acids 2021cited by 15position: middledoi
The essential role of long non-coding RNA GAS5 in glioma: interaction with microRNAs, chemosensitivity and potential as a biomarker
Journal of Cancer 2020cited by 19position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Jiajie Tu · Shandong University5 papers (2020–2022)Dafei Han · Ministry of Education of the People's Republic of China4 papers (2020–2022)Wenming Hong · Ministry of Education of the People's Republic of China4 papers (2020–2022)Yilong Fang · Ministry of Education of the People's Republic of China4 papers (2020–2022)Wei Wei · Kunming Medical University4 papers (2020–2022)Haifeng Jiang · Ministry of Education of the People's Republic of China4 papers (2020–2022)Xinming Wang · Anhui Medical University3 papers (2020–2022)Xu Zhen · Ministry of Education of the People's Republic of China2 papers (2021–2021)Xun Gong · University of Illinois Urbana-Champaign1 papers (2020–2020)Huan Yang · Institute of Infection and Immunity1 papers (2022–2022)Tao Li · Anhui Medical University1 papers (2021–2021)Zhiying Yu · Shenzhen University1 papers (2021–2021)Ya-Wei Guo · Ministry of Education of the People's Republic of China1 papers (2020–2020)Yuanyuan Zhang · Zhejiang Chinese Medical University1 papers (2022–2022)Yu Chen · Anhui Medical University1 papers (2022–2022)Xiaochun Chen · Fujian Medical University1 papers (2022–2022)Yizhao Chen · Ministry of Education of the People's Republic of China1 papers (2021–2021)Zhen Xu · Ministry of Education of the People's Republic of China1 papers (2022–2022)Zhe Li · National Heart Lung and Blood Institute1 papers (2022–2022)He Chen · Nanchang University1 papers (2022–2022)